Company intelligence / Profile preview

Rubix LS

Lawrence, Massachusetts, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Rubix LS develops culturally competent clinical research and technology focusing on early biomarker detection, targeted therapies, and equitable healthcare outcomes for underserved populations. It launched a therapeutics division and is pioneering inclusive clinical trials and real-world public health solutions. No specific clinical results or drug programs disclosed.

Industry: Contract Research Organization

Partnerships

360Medlink (digital health platform partnership for clinical trial innovation)

Beyond the preview

Go deeper on Rubix LS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rubix LS.

Explore the full profile